Dr. Fabien Plisson
In our group, we are interested in the discovery and design of peptide-based drugs. Peptides offer advantageous pharmacological characteristics, we design peptides for unmet medical needs and against agrochemical pests. We take advantage of knowledge discovery in databases (KDD) and scientific literature to better understand the relationships between structures, functions and the evolution of these peptides. We develop innovative methodologies including 'machine learning’ algorithms to accelerate the drug discovery and design process and support these studies.
To access all publications, click the following links: